The government is later today expected to make its fresh position on the Oxford-AstraZenecca vaccine.
A member of the Presidential Taskforce on Covid 19 has confirmed this to Capital FM as Malawi secures 1,476,000 doses of AstraZenecca vaccine.
The Global Vaccines Alliance-GAVI is providing the vaccine to Malawi for roll out next month, targeting frontline workers and vulnerable groups.
But South Africa has suspended the roll out of the AstraZenecca vaccine due to what is termed as disappointing results of a study on the new Covid variant.
A new medical study, involving around 2,000 people, found the vaccine offered “minimal protection” against mild and moderate cases of Covid-19.
Malawi is among countries that have been largely affected by the South Africa variant.
It is not known whether Malawi will follow the South Africa way or still roll it out next month.
In his last night’s address, President Lazarus Chakwera disclosed that the government is exploring other Covid 19 vaccine options to compliment the Oxford vaccine.
Meanwhile, a medical specialist hints that the country can still roll out the AstraZeneca vaccine, as not all vaccines have 100 percent efficacy.
Parth Patel who is also a member of the Society of Medical Doctors has told Capital FM that even if there are vaccines that are 90 % effective, there are also some people that will still contract the virus hence the need to strictly adhere to preventive measures